01 80ASTRAZENECA AB
02 322BOEHRINGER INGELHEIM
03 92JANSSEN PHARMS
04 26MSD SUB MERCK
05 1SANTARUS INC
06 1SUN PHARM
07 16TAKEDA PHARMS USA
01 510022379*PED
02 1210258637*PED
03 410596120*PED
04 410610489*PED
05 310973827*PED
06 1211090323*PED
07 96515117
08 56515117*PED
09 57326708
10 57326708*PED
11 97407955
12 97407955*PED
13 127579449
14 127579449*PED
15 127713938
16 127713938*PED
17 17780987
18 27785627
19 27807689
20 97919598
21 57919598*PED
22 247943582
23 87943788
24 27959946
25 48080580
26 28173663
27 248222219
28 28288539
29 28414921
30 98501698
31 248513202
32 48551957
33 910022379
34 1210258637
35 410406172
36 1610596120
37 410610489
38 310973827
39 1211090323
40 311564886
41 411576894
42 411813275
43 2411833166
44 511911388
45 28414921*PED
46 58501698*PED
47 48551957*PED
48 78628799
49 58673927
50 58673927*PED
51 58685934
52 58685934*PED
53 48716251
54 88785403
55 38846695
56 38846695*PED
57 98883805
58 98883805*PED
59 28900638
60 29101660
61 99155705
62 59155705*PED
63 29173859
64 29173859*PED
65 49308204
66 29320714
67 39339472
68 99415016
69 59415016*PED
70 49439902
71 49555001
72 29555001*PED
73 99616028
74 59616028*PED
75 169949997
76 89949997*PED
77 89949998
78 89949998*PED
79 19962336
01 121Y
02 417Blank
01 230Y
02 308Blank
01 82024-07-30
02 22025-03-15
03 12025-03-23
04 242025-04-11
05 92025-05-02
06 22025-06-24
07 102025-07-13
08 92025-10-04
09 92025-11-02
10 92025-11-26
11 52026-04-04
12 92026-05-26
13 42026-07-31
14 52026-11-24
15 22027-01-22
16 122027-04-15
17 72027-05-04
18 52027-05-24
19 92027-06-20
20 82027-07-14
21 122027-10-15
22 72027-11-04
23 242027-12-03
24 52027-12-20
25 42028-03-21
26 22028-06-27
27 22028-07-21
28 122028-08-01
29 22029-01-21
30 122029-02-01
31 22029-02-03
32 242029-02-26
33 212029-04-02
34 22029-05-24
35 132029-10-02
36 42029-10-14
37 92029-12-16
38 52030-04-10
39 42030-04-14
40 92030-05-21
41 52030-05-26
42 32030-06-04
43 42030-06-15
44 52030-06-16
45 42030-07-06
46 42030-07-13
47 42030-09-30
48 82030-10-21
49 92030-11-12
50 52030-11-21
51 52030-11-26
52 32030-12-04
53 42031-03-30
54 52031-05-12
55 192032-03-07
56 42032-09-07
57 42033-03-06
58 22033-09-06
59 522034-04-03
60 162034-05-17
61 82034-06-11
62 242034-10-03
63 82034-11-17
64 82034-12-11
65 12035-05-01
Patent Expiration Date : 2025-10-04
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 6515117
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 205649
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2025-10-04
Patent Expiration Date : 2025-10-04
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 6515117
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 205649
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2025-10-04
Patent Expiration Date : 2027-06-20
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8501698
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205649
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2027-06-20
Patent Expiration Date : 2025-10-04
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 6515117
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 205649
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2025-10-04
Patent Expiration Date : 2027-06-20
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8501698
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205649
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2027-06-20
Patent Expiration Date : 2030-05-26
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8685934
Drug Substance Claim :
Drug Product Claim :
Application Number : 205649
Patent Use Code : U-1522
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2030-05-26
Patent Expiration Date : 2025-10-04
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
US Patent Number : 6515117
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210874
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2025-10-04
Patent Expiration Date : 2025-10-04
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
US Patent Number : 6515117
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210874
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2025-10-04
Patent Expiration Date : 2027-06-20
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
US Patent Number : 8501698
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210874
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2027-06-20
Patent Expiration Date : 2027-06-20
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE
US Patent Number : 8501698
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210874
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2027-06-20
LOOKING FOR A SUPPLIER?
